title: Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin.
abstract: The serotonin release assay (SRA) tests for antibodies responsible for heparin-induced thrombocytopenia (HIT). By definition, SRA-positive antibodies cause platelet serotonin release in vitro, in the presence of low concentrations of heparin, but not with excess heparin. Many SRA-positive sera activate platelets in the presence of saline without drug, either as a result of residual heparin in the specimen, or because of intrinsic features of the HIT antibodies. The present experiments show that neither exhaustive heparinase treatment, nor chromatographic removal of heparin abrogates the spontaneous platelet activation caused by these HIT antibodies. This is the first study to systematically demonstrate that in vitro activity of HIT antibodies can be independent of heparin. In addition, T-gel chromatography demonstrated differences among fractions of enzyme-linked-immunosorbent assay (ELISA)-positive HIT antibodies within individual specimens. Certain ELISA-positive fractions had SRA activity while others did not, and the SRA activity was not proportional to HIT antibody ELISA titer. These data suggest that antibodies formed as a result of heparin treatment are heterogeneous, and that some can contribute to the pathogenesis of HIT even when heparin is no longer present.
authors.affiliation: Department of Pathology, Loyola University Medical Center, Maywood, IL 60153, USA. mpreche@lumc.edu
authors.forename: M M
authors.initials: MM
authors.lastname: Prechel
authors.forename: M K
authors.initials: MK
authors.lastname: McDonald
authors.forename: W P
authors.initials: WP
authors.lastname: Jeske
authors.forename: H L
authors.initials: HL
authors.lastname: Messmore
authors.forename: J M
authors.initials: JM
authors.lastname: Walenga
mesh_terms: D000906:Antibodies / Q000302:isolation & purification / Q000502:physiology*; D002250:Carbon Radioisotopes; D006493:Heparin / Q000009:adverse effects / Q000276:immunology*; D019763:Heparin Lyase / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000302:isolation & purification; D015539:Platelet Activation / Q000187:drug effects / Q000276:immunology*; D012701:Serotonin / Q000378:metabolism; D013921:Thrombocytopenia / Q000139:chemically induced / Q000276:immunology*; D013997:Time Factors
chemical_list: D000906:Antibodies; D002250:Carbon Radioisotopes; D007074:Immunoglobulin G; D012701:Serotonin; D006493:Heparin; D019763:Heparin Lyase